Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy
- 31 May 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (7) , 888-894
- https://doi.org/10.1016/j.ejca.2005.12.012
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cellsInternational Journal of Radiation Biology, 2004
- The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinomaCancer, 2002
- Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapyCancer, 2002
- CLINICAL PERSPECTIVE: Acromegaly and Cancer: A ProblemJournal of Clinical Endocrinology & Metabolism, 2001
- Identification of Genes Induced by Growth Hormone in Rat Liver Using cDNA ArraysEndocrinology, 2000
- Growth Hormone, Interferon-γ, and Leukemia Inhibitory Factor Utilize Insulin Receptor Substrate-2 in Intracellular SignalingPublished by Elsevier ,1996
- Carcinoma of the rectumDiseases of the Colon & Rectum, 1996
- Thep53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancersZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Evaluation of Preoperative Radiation Therapy in Operable Colorectal CancerAnnals of Surgery, 1994
- Local recurrence of rectal adenocarcinoma after ‘curative’ surgery with and without preoperative radiotherapyBritish Journal of Surgery, 1994